Menu
Back to Journals » Cancer Management and Research » Volume 12
RETRACTED ARTICLE: MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4
Authors Zheng RP, Ma DK, Li Z, Zhang HF
Received 9 April 2020
Accepted for publication 19 June 2020
Published 22 July 2020 Volume 2020:12 Pages 6165—6175
DOI https://doi.org/10.2147/CMAR.S257598
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Lu-Zhe Sun
This paper has been retracted.
Zheng RP, Ma DK, Li Z, Zhang HF. Cancer Manag Res. 2020;12:6165–6175.
We, the Editors and Publisher of Cancer Management and Research, have retracted the following article.
Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors were cooperative but were unable to address the concerns raised and have not been able to provide sufficient supporting information. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were informed of this decision.
We have been informed in our decision-making by our editorial policies and COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.